Date:8/1/2012

ty and equipment(833)(207)Release of restricted cash129-Proceeds from sale of property and equipment-26Net change in other assets-47Net cash used in investing activities(704)(134)Cash flows from financing activities:Repayment of capital lease lines of credit(438)(228)Proceeds from exercise of stock options9501,216Net cash provided by financing activities512988Effect of exchange rate changes on cash and cash equivalents(74)(141)Increase in cash and cash equivalents9623,624Cash and cash equivalents, at beginning of the period16,5829,376Cash and cash equivalents, at end of the period$17,544$13,000 

 STAAR Surgical CompanyGlobal Sales(in 000's)Three Months EndedYear EndedJune 29,July 1,%June 29,July 1,%Geographic Sales20122011Change20122011ChangeUnited States

20.2%

$  3,216

22.8%

$  3,705-13.2%20.3%

$  6,390

23.3%

$  7,238-11.7%Japan

25.7%

4,094

23.9%

3,8905.2%25.3%

7,951

24.9%

7,7342.8%Korea

10.8%

1,721

12.3%

2,009-14.3%11.5%

3,624

10.9%

3,3946.8%China

13.4%

2,141

11.1%

1,80318.7%13.5%

4,247

9.7%

3,00741.2%Other

29.9%

4,770

29.9%

4,862-1.9%29.4%

9,239

31.3%

9,745-5.2%  Total International Sales

79.8%

12,726

77.2%

12,5641.3%79.7%

25,061

76.7%

23,8804.9%Total Sales

100.0%

$15,942

100.0%

$16,269-2.0%100.0%

$31,451

100.0%

$31,1181.1%Product Sales  Core productsICLs

54.0%

$  8,606

51.0%

$  8,2933.8%54.7%

$17,211

48.8%

$15,19113.3%IOLs

42.5%

6,774

43.5%

7,076-4.3%41.8%

13,1
'/>"/>

SOURCE STAAR Surgical Company Copyright©2012 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Related medicine technology :

1. STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress
2. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
3. B. Riley Revises Timing of STAAR Surgical Presentation at Investor Conference
4. STAAR Surgical To Present At The Benchmark And Jefferies Investor Conferences
5. STAAR Surgical Provides Outlook On Second Quarter 2012 Financial Results
6. First Patient Treated in U.S. Clinical Study of Cohera Medicals TissuGlu® Surgical Adhesive
7. Bausch + Lomb Names John Barr Global President Surgical
8. Surgical Information Systems Recognizes Clients for Financial, Clinical, and Operational Improvements
9. Millennium Surgical Corp. Announces Sales Figures, Growth
10. Swiss Engineering for Surgical Perfection
11. Millennium Surgical Corp. Develops Online Sterilization Resource Center